Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
Clinical trial NCT04284488 · TERMINATED
Trial details
- NCT number
- NCT04284488
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2024-11-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.